Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Evaluation of factors influencing accuracy in the analysis of succinylacetone in dried blood spots.

Peng M, Liu L, Peng L.

Clin Chim Acta. 2012 Aug 16;413(15-16):1265-9. doi: 10.1016/j.cca.2012.04.006. Epub 2012 Apr 12.

PMID:
22522056
2.

Improved method to determine succinylacetone in dried blood spots for diagnosis of tyrosinemia type 1 using UPLC-MS/MS.

Al-Dirbashi OY, Rashed MS, Jacob M, Al-Ahaideb LY, Al-Amoudi M, Rahbeeni Z, Al-Sayed MM, Al-Hassnan Z, Al-Owain M, Al-Zeidan H.

Biomed Chromatogr. 2008 Nov;22(11):1181-5. doi: 10.1002/bmc.1049.

PMID:
18651606
3.

[Application of succinylacetone levels measurement in the blood and urine in the diagnosis of tyrosinemia type 1].

Han LS, Ye J, Qiu WJ, Zhang HW, Wang Y, Ji WJ, Gao XL, Li XY, Jin J, Gu XF.

Zhonghua Er Ke Za Zhi. 2012 Feb;50(2):126-30. Chinese.

PMID:
22455637
4.

Quantitative determination of succinylacetone in dried blood spots for newborn screening of tyrosinemia type I.

Magera MJ, Gunawardena ND, Hahn SH, Tortorelli S, Mitchell GA, Goodman SI, Rinaldo P, Matern D.

Mol Genet Metab. 2006 May;88(1):16-21. Epub 2006 Jan 31.

PMID:
16448836
5.

Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume.

Vu DH, Koster RA, Alffenaar JW, Brouwers JR, Uges DR.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 May 1;879(15-16):1063-70. doi: 10.1016/j.jchromb.2011.03.017. Epub 2011 Mar 16.

PMID:
21459055
6.

The inclusion of succinylacetone as marker for tyrosinemia type I in expanded newborn screening programs.

la Marca G, Malvagia S, Pasquini E, Innocenti M, Fernandez MR, Donati MA, Zammarchi E.

Rapid Commun Mass Spectrom. 2008;22(6):812-8. doi: 10.1002/rcm.3428.

PMID:
18278819
7.

Newborn screening for hepatorenal tyrosinemia: Tandem mass spectrometric quantification of succinylacetone.

Sander J, Janzen N, Peter M, Sander S, Steuerwald U, Holtkamp U, Schwahn B, Mayatepek E, Trefz FK, Das AM.

Clin Chem. 2006 Mar;52(3):482-7. Epub 2006 Jan 26.

8.

Evaluation of a novel, commercially available mass spectrometry kit for newborn screening including succinylacetone without hydrazine.

Metz TF, Mechtler TP, Merk M, Gottschalk A, Lukačin R, Herkner KR, Kasper DC.

Clin Chim Acta. 2012 Aug 16;413(15-16):1259-64. doi: 10.1016/j.cca.2012.04.007. Epub 2012 Apr 12.

PMID:
22521492
9.

Development and validation of a sensitive LC-MS/MS method for determination of tacrolimus on dried blood spots.

Li Q, Cao D, Huang Y, Xu H, Yu C, Li Z.

Biomed Chromatogr. 2013 Mar;27(3):327-34. doi: 10.1002/bmc.2795. Epub 2012 Aug 15.

PMID:
22893355
10.

Liquid chromatography-mass spectrometric determination of losartan and its active metabolite on dried blood spots.

Rao RN, Raju SS, Vali RM, Sankar GG.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Aug 1;902:47-54. doi: 10.1016/j.jchromb.2012.06.013. Epub 2012 Jun 19.

PMID:
22770781
11.

Newborn screening for hepatorenal tyrosinemia-I by tandem mass spectrometry using pooled samples: a four-year summary by the New England newborn screening program.

Zytkovicz TH, Sahai I, Rush A, Odewale A, Johnson D, Fitzgerald E, Britton D, Eaton RB.

Clin Biochem. 2013 May;46(7-8):681-4. doi: 10.1016/j.clinbiochem.2013.02.002. Epub 2013 Feb 24.

PMID:
23462696
12.

Quantitative determination of atenolol in dried blood spot samples by LC-HRMS: a potential method for assessing medication adherence.

Lawson G, Cocks E, Tanna S.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 May 15;897:72-9. doi: 10.1016/j.jchromb.2012.04.013. Epub 2012 Apr 16.

PMID:
22552005
13.

LC-MS/MS bioanalysis of loratadine (Claritin) in dried blood spot (DBS) samples collected by subjects in a clinical research study.

Li W, Doherty J, Moench P, Flarakos J, Tse FL.

J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Mar 1;983-984:117-24. doi: 10.1016/j.jchromb.2014.12.033. Epub 2015 Jan 13.

PMID:
25645810
14.

Tandem mass spectrometric determination of succinylacetone in dried blood spots enables presymptomatic detection in a case of hepatorenal tyrosinaemia.

Weigel JF, Janzen N, Pfäffle RW, Thiery J, Kiess W, Ceglarek U.

J Inherit Metab Dis. 2007 Aug;30(4):610. Epub 2007 Aug 10.

PMID:
17694358
15.
16.

Succinylacetone as primary marker to detect tyrosinemia type I in newborns and its measurement by newborn screening programs.

De Jesús VR, Adam BW, Mandel D, Cuthbert CD, Matern D.

Mol Genet Metab. 2014 Sep-Oct;113(1-2):67-75. doi: 10.1016/j.ymgme.2014.07.010. Epub 2014 Jul 17.

17.

Application of automated serial blood sampling and dried blood spot technique with liquid chromatography-tandem mass spectrometry for pharmacokinetic studies in mice.

Wong P, Pham R, Whitely C, Soto M, Salyers K, James C, Bruenner BA.

J Pharm Biomed Anal. 2011 Nov 1;56(3):604-8. doi: 10.1016/j.jpba.2011.06.022. Epub 2011 Jul 1.

PMID:
21784595
18.

LC-MS/MS method for simultaneous determination on a dried blood spot of multiple analytes relevant for treatment monitoring in patients with tyrosinemia type I.

la Marca G, Malvagia S, Materazzi S, Della Bona ML, Boenzi S, Martinelli D, Dionisi-Vici C.

Anal Chem. 2012 Jan 17;84(2):1184-8. doi: 10.1021/ac202695h. Epub 2011 Dec 29. Erratum in: Anal Chem. 2014 Oct 21;86(20):10501.

PMID:
22148291
19.

On-line liquid chromatography/tandem mass spectrometry simultaneous determination of opiates, cocainics and amphetamines in dried blood spots.

Saussereau E, Lacroix C, Gaulier JM, Goulle JP.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Feb 15;885-886:1-7. doi: 10.1016/j.jchromb.2011.11.035. Epub 2011 Dec 2.

PMID:
22281234
20.

Combined newborn screening for succinylacetone, amino acids, and acylcarnitines in dried blood spots.

Turgeon C, Magera MJ, Allard P, Tortorelli S, Gavrilov D, Oglesbee D, Raymond K, Rinaldo P, Matern D.

Clin Chem. 2008 Apr;54(4):657-64. doi: 10.1373/clinchem.2007.101949. Epub 2008 Feb 15.

Supplemental Content

Support Center